TP53 and neoplasm: Because the loss of the ability of tumour cells to activate apoptosis following treatment with radiation or chemotherapy is one of the most frequent alterations that occur in solid tumours, the elucidation of the pathways that control p53-dependent and p53-independent cell death should provide new strategies for the development of more effective drugs.